Connect with us

Medical Research

New Marijuana Study: Recreational Cannabis Use on the Rise for Insomnia




The University of New Mexico newsroom reported a study on the use of recreational cannabis to treat insomnia. The study, titled Using Recreational Cannabis to Treat Insomnia: Evidence from Over-The-Counter Sleep Aid Sales in Colorado, conducted by researchers at the University of Mexico (UNM) and California State Polytechnic University (CalPoly) found that medical cannabis may be an effective method to alleviate insomnia.

Assistant Professor Jacqueline Doremus (CalPoly, Economics), Assistant Professor Sarah Stith (UNM, Economics) and Associate Professor Jacob Vigil (UNM, Psychology) authored the study, and determined that access to recreational cannabis reduced demand for sleep aids purchased over the counter. The researchers looked at the largest repository of UPC-level scanner data in the country, which was collected by the Nielsen Company. Upon creating a market share for OTC sleep aids, researchers measured how the store-level OTC sleep aid market shares changed when recreational cannabis dispensaries were in the same county in which the store was located.

Doremus shared in the news report that by observing large data sets and “natural” or “quasi-experimental research designs,” it is possible to gain insight into the impact of cannabis in an area where traditional approaches have not had very much success in providing the information necessary for information’s to make informed decisions concerning their use of cannabis.

Stith added that the study has important implications, such as from a public health perspective.

She stated,

“From a public health perspective, the possible widespread use of cannabis for less severe medical conditions both highlights its therapeutic potential and raises concerns regarding the risk-benefit tradeoffs of substituting a substance associated with abuse and dependence for relatively ineffective OTC medications with typically low levels of abuse potential.”

She also addressed the economic or business perspective has implications for a multimillion-dollar US market that includes OTC sleep aids.

Vigil also shared in the report that the absence of medical guidance does not necessarily mean that there is a lack of medical use.

Michael is a freelance writer with several years of experience in writing of all kinds. From the uber-technical to the more relaxed, he is well-versed in a variety of styles. Lately, his work has been primarily focused on the CBD industry—a market with which he has a particular background and interest. Michael has an extensive interest and experience in legal research for the CBD market, and he has a knack for well-researched pieces and guides for the growing CBD and medicinal cannabis community.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.